Longitudinal analyses of electronic medical records reveal dynamic developmental trajectories for patients with SCN8A ‐related disorders

Documenti analoghi

• Patients carrying pathogenic SCN8A variants with loss‐ and gain‐of‐function effects can be classified into five subgroups exhibiting varying developmental and epileptic components of encephalopathy
  di: Joshua B. Hack, et al.
  Pubblicazione: (2024)
• Global modified‐Delphi consensus on comorbidities and prognosis of SCN8A‐related epilepsy and/or neurodevelopmental disorders
  di: Gabrielle Conecker, et al.
  Pubblicazione: (2024)
• Cenobamate as add‐on treatment for SCN8A developmental and epileptic encephalopathy
  di: Cathrine E. Gjerulfsen, et al.
  Pubblicazione: (2025)
• Genotype–phenotype associations in 1018 individuals with SCN1A‐related epilepsies
  di: Declan Gallagher, et al.
  Pubblicazione: (2024)
• Clinical trajectories and medication response in TBC1D24 ‐related epilepsies
  di: Ealing Mondragon, et al.
  Pubblicazione: (2025)